Budapest, Hungary

Maria Lovas Nee Marsai

This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Lovas Nee Marsai. Retrieved from https://idiyas.com/inventor/maria-lovas-nee-marsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Lovas Nee Marsai: Innovator in Muscle Relaxant Development

Introduction

Maria Lovas Nee Marsai is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmacology, particularly in the development of muscle relaxants. Her innovative work has led to the creation of new compounds that exhibit curare-like muscle relaxant activity.

Latest Patents

Maria holds a patent for "Diamino-androstane derivatives." This patent discloses new monoquaternary and diquaternary 5-alpha-hydroxy-3,16-diaminoandrostane salts. These salts are characterized by a surprisingly rapid onset time, making them valuable in medical applications.

Career Highlights

Maria is associated with Richter Gedeon Vegyeszeti Gyar Rt., a leading pharmaceutical company in Hungary. Her work at this company has allowed her to focus on innovative drug development and contribute to advancements in muscle relaxant therapies.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues, including Zoltan Tuba and Judit Horvath. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Maria Lovas Nee Marsai is a trailblazer in the field of muscle relaxants, with her innovative patents paving the way for future advancements in pharmacology. Her contributions continue to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…